BT

BioAffinity Technologies

BIAF

NASDAQHealth Care

Income Statement

Total Revenue$8.81M

Gross Profit$3.03M

Operating Income$0

EBITDA$0

EBIT$-9.64M

Pre-tax Income$-9.72M

Net Income$-9.74M

Balance Sheet

Cash Equivalent$444.7K

Total Debt$892.4K

Book Value$2.6

Book Value Per Share0.17

Key Ratios

Return on Equity (ROE)-347.41%

Return on Assets (ROA)-138.78%

Return on Invested Capital (ROI)-248.78%

Net Profit Margin-96.56%

Current Ratio0.87

Quick Ratio0.78

Long-Term Debt / Equity0.01